MinShan Chen
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
-
- Cancer Mechanisms and Therapy
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Liver Disease and Transplantation 1
- Hepatitis C virus research 1
-
- Hedgehog Signaling Pathway Studies 1
- Co-authors
- Ming Shi (4 shared papers)Li Xu (5 shared papers)QiJiong Li (4 shared papers)Minke He (3 shared papers)Wei Wei (3 shared papers)JingXian Shen (2 shared papers)Zhongguo Zhou (4 shared papers)Ming Zhao (1 shared paper)
- Journals
- Hepatology Research (1 paper)Clinical Cancer Research (1 paper)Acta Pharmacologica Sinica (1 paper)European Journal of Cancer (1 paper)JAMA Oncology (1 paper)
- Partner nations
- China
In The Last Decade
MinShan Chen
9 papers receiving 612 citations
MinShan Chen's Hit Papers
Peers
Comparison fields: 5 of 40
- Hepatology 436
- Pathology and Forensic Medicine 87
- Oncology 71
- Cancer Research 39
- Complementary and alternative medicine 15
Countries citing papers authored by MinShan Chen
This map shows the geographic impact of MinShan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MinShan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MinShan Chen more than expected).
Fields of papers citing papers by MinShan Chen
This network shows the impact of papers produced by MinShan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MinShan Chen. The network helps show where MinShan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside MinShan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion Hit paper breakdown → | 2019 | 386 |
| 2 | Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial Hit paper breakdown → | 2022 | 122 |
| 3 | 2021 | 42 | |
| 4 | 2010 | 23 | |
| 5 | 2023 | 18 | |
| 6 | 2020 | 10 | |
| 7 | 2022 | 6 | |
| 8 | 2025 | 5 | |
| 9 | 2011 | 2 |
About MinShan Chen
MinShan Chen is a scholar working on Hepatology, Molecular Biology, Pathology and Forensic Medicine, Epidemiology and Public Health, Environmental and Occupational Health, having authored 9 papers that have together received 614 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Mechanisms and Therapy (2 papers), Hedgehog Signaling Pathway Studies (1 paper), Liver Disease and Transplantation (1 paper), Microtubule and mitosis dynamics (1 paper), Hepatitis C virus research (1 paper), Natural Compounds in Disease Treatment (1 paper) and Liver Disease Diagnosis and Treatment (1 paper). The work is most often cited by research in Hepatology (436 citations), Pathology and Forensic Medicine (87 citations), Oncology (71 citations), Cancer Research (39 citations) and Complementary and alternative medicine (15 citations). MinShan Chen has collaborated with scholars based in China. Frequent co-authors include Ming Shi, Li Xu, QiJiong Li, Minke He, Wei Wei, JingXian Shen, Zhongguo Zhou, Ming Zhao, Yong Le and Rong Guo. Their work appears in journals such as Hepatology Research, Clinical Cancer Research, Acta Pharmacologica Sinica, European Journal of Cancer and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.